M&A: Boston Scientific buying Asthmatx

Boston Scientific Corp. (NYSE:BSX) will acquire fellow medical device company Asthmatx Inc. (Sunnyvale, Calif.) for $193.5 million up front in cash, plus up to $250 million in revenue-based milestones...